lifestyle.capitolhilltimes.com

  • Animals
  • Auto
  • Beauty & Style
  • Business News
  • Entertainment
  • Food
  • Health
  • Home & Family
  • Podcasts
  • Tech
  • Travel

Business

Latest Business News

  • OrthoPediatrics Announces Expanded Enabling Technology Market Opportunity

    OrthoPediatrics Announces Expanded Enabling Technology Market Opportunity

    OrthoPediatrics Corp.
    February 3, 2026
  • Relay Therapeutics Announces Zovegalisib Granted Breakthrough Therapy Designation by U.S. FDA for PIK3CA-mutant, HR+/HER2- Advanced Breast Cancer

    Relay Therapeutics Announces Zovegalisib Granted Breakthrough Therapy Designation by U.S. FDA for PIK3CA-mutant, HR+/HER2- Advanced Breast Cancer

    Relay Therapeutics, Inc.
    February 3, 2026
  • Tango Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026

    Tango Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026

    Tango Therapeutics Sub, Inc
    February 3, 2026
  • X4 Pharmaceuticals to Participate in Guggenheim’s Emerging Outlook: Biotech Summit 2026

    X4 Pharmaceuticals to Participate in Guggenheim’s Emerging Outlook: Biotech Summit 2026

    X4 Pharmaceuticals
    February 3, 2026
  • International Battery Metals Ltd. to Present at the OTC Precious Metals and Critical Minerals Conference

    International Battery Metals Ltd. to Present at the OTC Precious Metals and Critical Minerals Conference

    Virtual Investor Conferences
    February 3, 2026
  • Cyber Acoustics Expands Monitor-Mounted Speaker Bar Line with New CA-2890GX Featuring Dynamic LED Lights

    Cyber Acoustics Expands Monitor-Mounted Speaker Bar Line with New CA-2890GX Featuring Dynamic LED Lights

    Cyber Acoustics, Inc.
    February 3, 2026
  • Foghorn Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit

    Foghorn Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit

    Foghorn Therapeutics, Inc.
    February 3, 2026
  • NMD Pharma announces topline results from its Phase 2a study of ignaseclant in Charcot-Marie-Tooth disease Types 1 and 2

    NMD Pharma announces topline results from its Phase 2a study of ignaseclant in Charcot-Marie-Tooth disease Types 1 and 2

    NMD Pharma
    February 3, 2026
  • Avacta Announces Two Key Clinical Updates to its Faridoxorubicin Program

    Avacta Announces Two Key Clinical Updates to its Faridoxorubicin Program

    AVACTA GROUP PLC
    February 3, 2026
  • Window World of Kalamazoo Highlights Ongoing Focus on Quality and Home Performance

    Window World of Kalamazoo Highlights Ongoing Focus on Quality and Home Performance

    EIN Newswire
    February 3, 2026
Prev
1 … 10,202 10,203 10,204 10,205 10,206 … 30,434
Next

Channels

Follow Us

  • X
  • LinkedIn

All content ©2025 Tork Media
All Rights Reserved. For more information on this site, please read our Privacy Policy, Terms of Service, Cookie Policy, and Ad Choices.